![](https://econcrimecompliance-ch.com/sites/default/files/styles/panopoly_image_square/public/speakers/mo_faisal_headshot.png?itok=LmnurRSm&c=babb14635ac9c006f14daa7331116a40)
Mo Faisal
Prior to founding Movellus, Mo held positions at semiconductor companies including Intel and PMC Sierra. He received his B.S. from the University of Waterloo, and his M.S. and Ph.D. from the University of Michigan, and holds several patents. Mo was named a “Top 20 Entrepreneur” by the University of Michigan Zell Lurie Institute.
![](https://econcrimecompliance-ch.com/sites/default/files/styles/panopoly_image_square/public/speakers/colin_murdoch_headshot.jpg?itok=gPO5y68-&c=004d8f3dc8f19664c51d678147a156c6)
Colin Murdoch
Decades of international commercial experience and deep technical expertise mean Colin is uniquely placed to ensure DeepMind’s cutting-edge research benefits as many people as possible. As Chief Business Officer of DeepMind, he oversees a wide-range of teams including Applied, which applies research breakthroughs to Google products and infrastructure used by billions of people. He also helps drive the growth of DeepMind, building and leading critical functions including finance and strategy and leading external and commercial partnerships. Originally an electronics and software engineer, he has held senior positions at both start-ups and global companies such as Thomson Reuters, helping them solve their own complex, mission-critical, real-world challenges.
![](https://econcrimecompliance-ch.com/sites/default/files/styles/panopoly_image_square/public/speakers/1516302671080.jpg?itok=vVFTBfUd&c=8273037cd3297c5492893585277d765d)
Max Rossetto
![](https://econcrimecompliance-ch.com/sites/default/files/styles/panopoly_image_square/public/speakers/15.08.03_1510_takanori_abe.jpg?itok=LBPShLpH&c=3ce16c59aab7abff4c457ce41d5af246)
Takanori Abe
Mr. ABE is an Attorney-at-Law, admitted in both Japan and New York. He is currently a Guest Professor of Osaka University Graduate School of Medicine and formerly a lecturer of The University of Tokyo Graduate School of Medicine and Faculty of Medicine. He is an arbitrator in Japan and sit on various positions in Japanese medical/pharmaceutical societies.
Mr. ABE works in wide areas of international and corporate matters with a focus on intellectual property law and international commerce. The patent litigations that he has participated covers the fields of pharmaceuticals, chemistry, electronics and machinery, which involve advanced technology such as biotechnology, semiconductors, etc., and which are cross-border matters. He has extensive experience on representing and advising multinational and domestic clients in pharmaceutical industry and is currently involved in the drastic battle between brands and also the one between brands and generics. He also has experience in trademark, copyright and unfair competition litigation.
For Mr. ABE’s detail information and activities, please visit www.abe-law.com or email to: [email protected]